Shalin Shah, CEO of Marius Pharmaceuticals, which makes an oral testosterone replacement drug, thinks TRT therapy should no longer be regulated as a controlled substance
Joining the conversation are Serge Perras of Abarca Health; Ton Roelandse with Trexin Consulting; and Bertil Chappuis of Xtillion.
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.
Pharmacy benefit managers are under scrutiny for their business practices that are often blamed for contributing to the rising costs of prescription drugs in America. But one PBM is paving another way that alters the traditional operating model.
Dr. Iftach Dolev, a neuroscientist and CEO of QuantalX, explained how his company's new FDA-cleared de novo device can bring a powerful tool to psychiatrists and neurologists alike. He claims this marks an important moment for brain health.
The impact AI is having on the healthcare experience.
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
Dr. Rowland Illing explained how life science companies and health systems are leveraing AWS HealthLake to transform healthcare.
In this episode, a pharmacy benefit management executive and a pharmacy startup talk about why benefit verification, prior authorizations, and patient affordability still break the workflow and how smart integrations, real-time eligibility, and intuitive design can reduce friction for all involved.
Smarter Technologies CEO Jeremy Delinsky explains how the company's AI infrastructure can help support health system's clinical documentation improvement efforts, ultimately strengthening RCM.
Yusuf Qasim, president of payments optimization at Zelis, talks about how his company’s platform is seeking to rebuild the healthcare payment process. The platform aims to eliminate unnecessary manual work for both payers and providers. Watch or listen now!
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
CoraVie Medical CEO Aimee Garza and Dr. Michael Bloch, a hypertension specialist and clinical advisor for the startup, talk about why the healthcare industry needs a better approach to blood pressure monitoring. CoraVie is developing an implantable device that measures patients’ blood pressure, operating in a similar way to continuous glucose monitors. Watch or listen now!
In this latest episode, Arundhati explores how one Mayo Clinic doctor found purpose in her deeply personal tragedy and how Mayo Clinic Florida then took her idea, executed on it and is attempting to scale it.
In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come.
Megan Zakrewsky, vice president of product at Veradigm talks about how the company is utilizing tech among providers, payers and patients. Watch now!
Ben Zeskind, co-founder, president and CEO of Immuneering, is attempting a new approach to treat certain types of cancers. If it works, there will be a vast improvement in the quality of life of cancer patients.